SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Genta tumbled from 1 1/4 to 1/2 last week on news that the company was running out of money this September. It has since rebounded sharply today to 1 1/8. I've heard that the company is planning on splitting itself in two, an antisense company and a drug delivery company. Is this true? Does anyone have information on what course GNTA might take?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1870GOT HIT AFTER DATA DIDNT SIGNIFY TOO MUCH!030s-040s..mlkr-10/29/2009
1869Tuck, it would not surprise me at all to see this kind of shenanigans going on iArt Bechhoefer-4/27/2007
1868>>CHMP Adopts Negative Opinion on Genasense(R) Application in Melanoma Frituck-4/27/2007
1867Yes, the new melanoma testing is good news, but what I don't understand is wArt Bechhoefer-4/23/2007
1866good news genta.comptlusa-4/23/2007
1865We're still waiting for word on what the European regulators decide regardinArt Bechhoefer-1/27/2007
1864Maybe? You're not usually so reticent, Dew.tom pope-1/27/2007
1863<i>email said there was some big money news on this one i think there may DewDiligence_on_SI-1/27/2007
1862email said there was some big money news on this one i think there may be somethptlusa-1/27/2007
1861looks like these guys are coming back i got a hot-stock notice about them in theptlusa-1/27/2007
1860Jim, isn't it ironic that after such a long time with generally good soundinArt Bechhoefer-12/18/2006
1859Thomas ... I would have to defer to others ..... regards, JohnJohn McCarthy-2/22/2006
1858Any views on the announcement last week of efficacy findings in PIII? TIA. CliThomas-2/22/2006
1857Analysis of Genasense(R) Trial Confirms Major Efficacy Variables in Patients witJohn McCarthy-2/2/2006
1856Genta Cites Leukemia Successes By PETER LOFTUS DOW JONES NEWSWIRES September 2Doc Bones-9/20/2005
1855Genta: Data From Phase 3 Trial Of Genasense Confirm Extended Durability Of RemisJim Oravetz-9/19/2005
1854Genta Announces Common Stk Offering Totaling Approximately $17.5M DOW JONES NEWSJim Oravetz-8/8/2005
1853Genta Says Study Shows Genasense Effective [EOM] DOW JONES NEWSWIRES June 13, 20Jim Oravetz-6/13/2005
1852Updated Analysis From Phase 3 Trial Of Genasense(R) In CLL Shows Significant IncJim Oravetz-5/17/2005
1851[G3139 -- PII with dexamethasone & thalidomide in relapsed MM] >>JCO tuck-5/10/2005
1850Genta And Aventis Terminate Genasense(R) Agreements DOW JONES NEWSWIRES May 10, Jim Oravetz-5/10/2005
1849>[Genasense + Rituxan versus lymphoma] >Mol Cancer Ther. 2004;3:1693-1699tuck-1/11/2005
1848Genta Announces Sale Of 15M Shrs At $1.50/Shr EOMJim Oravetz-12/15/2004
1847Genta Cancer Drug Fails Late-Stage Trial Friday November 26, 8:43 am ET GentaDoc Bones-11/26/2004
1846Genta Cancer Drug Fails Late-Stage Trial Friday November 26, 8:52 am ET NEW YDoc Bones-11/26/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News